Does the GSL really carry a "poison pill" clause that forbids companies making GSL-based products from making any OGL-based products?
If so, will there be an exception to allow for the continued sale of existing OGL products indefinitely, so long as no more are made?
Also (if the "poison pill" clause is there) will there be language to prevent companies from creating subsidiary/sister companies to publish OGL products while the main company publishes GSL products (or vice versa)?
Also (if the "poison pill" clause is there) will there be penalties for companies who make GSL-based products, and then produce an OGL product?
Also (if the "poison pill" clause is there) is there a chance it could be limited solely to products that reference the d20 or Modern d20 SRDs in the OGL Section 15, rather than extending to the entire OGL?